神吉康晴

KANKI Yasuharu

研究分野 (1件)：分子生物学

競争的資金等の研究課題 (14件)：

全件表示

論文 (36件)：

Yuji Sasaki, Yoshiki Higashijima, Jun-Ichi Suehiro, Takehito Sugasawa, Eri Oguri-Nakamura, Shigetomo Fukuhara, Nao Nagai, Yosuke Hirakawa, Youichiro Wada, Masaomi Nangaku, et al. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors. Biochemical and Biophysical Research Communications. 2022. 605. 16-23
Yasuharu Kanki, Masashi Muramatsu, Yuri Miyamura, Kenta Kikuchi, Yoshiki Higashijima, Ryo Nakaki, Jun-Ichi Suehiro, Yuji Sasaki, Yoshiaki Kubota, Haruhiko Koseki, et al. Bivalent-histone-marked immediate-early gene regulation is vital for VEGF-responsive angiogenesis. Cell reports. 2022. 38. 6. 110332-110332
Takashi Shimizu, Akashi Taguchi, Yoshiki Higashijima, Yasuharu Kanki, Ryo Nakaki, Yoshihiro Urade, Youichiro Wada. Inhibition of cardiac PERK signaling promotes peripartum cardiac dysfunction. Scientific reports. 2021. 11. 1. 18687-18687
Kiyokazu Shirai, Genta Nagae, Motoaki Seki, Yotaro Kudo, Asuka Kamio, Akimasa Hayashi, Atsushi Okabe, Satoshi Ota, Shuichi Tsutsumi, Takanori Fujita, et al. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma. Cancer science. 2021. 112. 7. 2855-2869
Yoshiki Higashijima, Yasuharu Kanki. Potential roles of super enhancers in inflammatory gene transcription. The FEBS journal. 2021

MISC (14件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

神吉 康晴